LSLeila Maria Soravia

Leila Maria Soravia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Leila Maria Soravia has a total of 97 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Social stress and psychosis: how cortisol shapes personal space regulation in schizophrenia

    by Adamantini Hatzipanayioti, Natalia Cavojska, Sebastian Walther, Nicole Gangl, Frauke Conring, Lea Schäppi, Leila M. Soravia, Mélodie Derome, Katharina Stegmayer

  • Open Access

    Bivariate Multiscale Sample Entropy of Frontoparietal-Subgenual ACC Dynamics in Depression During Accelerated TMS at 7 T

    by Niklaus Denier, Matthias Grieder, Kay Jann, Pascal Borel, Stefan Dendorfer, Gianluca Andri Florineth, Kristina Adorjan, Andrea Federspiel, Roland Wiest, Leila Maria Soravia, et al.

    Objective: To examine whether longitudinal changes in frontoparietal (FP) - subgenual anterior cingulate cortex (sgACC) joint temporal complexity differ between sgACC hemispheres in patients undergoing accelerated TMS (aTMS) and untreated healthy controls. Methods: Twenty-four patients with current depressive episodes and fifteen healthy controls underwent 7T resting-state fMRI at baseline and follow-up. Patients received aTMS localized to the left DLPFC using Beam-F3. The same bilateral FP time series was paired separately with left and right sgACC time series. Bivariate multiscale sample entropy (bMSE) across scale factors a1-a10 was summarized by trapezoidal integration as a complexity index (bMSE-CI). The primary test was the Group x Time x sgACC Hemisphere interaction in a mixed repeated-measures ANOVA. Scale-specific interactions and clinical Spearman correlations were evaluated with Benjamini-Hochberg false discovery rate correction. Change scores were follow-up minus baseline. Results: The bMSE-CI Group x Time x Hemisphere interaction was significant (F(1,37) = 6.043, p = 0.0188, partial Eta squared = 0.140). Mean left/right bMSE-CI changes were -0.286/+0.124 in patients and +0.323/+0.112 in controls. Of ten scale-specific three-way interactions, only a2 survived FDR correction (q = 0.0435). No baseline or change-score bMSE-MADRS association survived the specified FDR corrections. A random-intercept-only mixed-model sensitivity analysis did not reach statistical significance for the three-way interaction (p = 0.0718). Conclusion: FP-sgACC joint temporal complexity showed hemisphere-dependent longitudinal differences between patients undergoing aTMS and healthy controls. These exploratory findings motivate further evaluation of bMSE as a candidate measure of longitudinal neural change in depression. Independent replication, more precise reliability estimates, and prospective validation of clinical relevance are needed.

  • Open Access

    Patient-related aggression distress and emotional exhaustion in Swiss psychiatric nurses: a sequential mediation model involving posttraumatic stress and depersonalization

    by Leila M. Soravia, Gianluca A. Florineth, Blerta Latifi Wermuth, Mario Pfammatter, Niklaus Denier, Thomas Müller, Christian Imboden, Nanja Schlup, Marc Walter, Ingo Butzke, et al.

    Background: Psychiatric nurses frequently encounter workplace violence, increasing their risk for psychological distress. This study examines how general workplace stressors relate to patient-related aggression (PRA) distress and clarifies the psychological pathway through which PRA-distress translates into emotional exhaustion via post-traumatic stress symptoms (PTSS) and depersonalization. Methods: An online survey was conducted with 317 psychiatric nurses across six Swiss hospitals. Instruments assessed PRA distress (adaptation of the POPAS), workplace stressors, self-efficacy (GSE), posttraumatic stress symptoms (PTSS-10), and subscales of burnout (MBI). Bivariate correlations examined the association between workplace stressors and PRA-distress, and a sequential mediation analysis (PROCESS Model 6, 5,000 bootstrap resamples, N = 278) tested whether PTSS and depersonalization sequentially mediated the effect of PRA-distress on emotional exhaustion, controlling for age, employment percentage, and self-efficacy. Results: Workplace stressors were strongly associated with PRA-distress ( r = .63, p <.001), indicating that aggression-related distress is embedded within broader organizational strain. In the mediation model ( R ² = .589), PRA-distress predicted PTSS ( b = 0.29, p <.001), which predicted depersonalization ( b = 0.24, p <.001) alongside a direct effect of PRA-distress on depersonalization ( b = 0.10, p = .042). Both PTSS ( b = 0.80) and depersonalization ( b = 0.74, both p <.001) strongly predicted emotional exhaustion, and the total indirect effect was significant ( b = 0.36, 95% CI [0.20, 0.51]). The direct effect of PRA-distress on exhaustion remained significant ( b = 0.19, p = .022), indicating partial mediation. Self-efficacy and age were protective, associated with lower PTSS/exhaustion and depersonalization/exhaustion, respectively. Conclusion: Patient-related aggression distress was associated with emotional exhaustion both directly and through a sequential pathway of traumatic stress and depersonalization, while remaining embedded in broader organizational strain. These findings point to immediate, post-incident trauma support, self-efficacy-building interventions, and systemic efforts to reduce structural workplace stressors as promising directions for future intervention research, rather than as established recommendations given the cross-sectional design.

  • Open Access

    Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis

    by Gianluca A. Florineth, Anna L. Boeker, Tobias Bracht, Alexander Wopfner, Niklaus Denier, Kristina Adorjan, Felix Müller, Leila M. Soravia

    Background: Psilocybin-assisted therapy (PAT) has emerged as a promising intervention for alcohol use disorder (AUD), yet contemporary clinical evidence has not been systematically synthesized to validate its clinical utility and safety profile. Methods: Contemporary clinical trials of PAT for AUD were identified systematically from PubMed, PsycINFO, and Scopus by two independent reviewers. Random-effects meta-analyses were conducted to synthesize within-group pre–post changes and between-group differences from randomized controlled trials (RCTs). Primary outcomes included continuous drinking measures and abstinence rates; secondary outcomes included adverse events (AEs). Results: Six trials ( N = 202) met inclusion criteria (3 RCTs). PAT produced significant within-group reductions across all drinking outcomes that were sustained at mid- to long-term follow-up (4–28 weeks). Compared to controls, psilocybin demonstrated moderate short-term advantages for drinks per day (standardized mean differences (SMD) = 0.48; p = 0.004), percent drinking days (SMD = 0.50; p = 0.009), and percent heavy drinking days (SMD = 0.39; p = 0.020). At mid- to long-term follow-up, only percent drinking days remained significantly superior (SMD = 0.41; p = 0.032). Psilocybin-treated patients had significantly higher odds of maintaining abstinence compared to controls (OR = 2.78; p = 0.029). AEs were predominantly mild and transient. Conclusions: Current evidence for PAT in AUD is mixed but suggests preliminary signals of efficacy for reducing alcohol consumption and increasing the odds of maintaining long-term abstinence. The intervention was well-tolerated with a favorable safety profile, supporting its potential as a novel treatment option.

  • Open Access

    Beyond the substance: A systematic review of psychological treatment frameworks in psychedelic-assisted therapy

    by Gianluca A. Florineth, Anna L. Boeker, Felix Müller, Tobias Bracht, Niklaus Denier, Antonia C. Jung, Alexander Wopfner, Kristina Adorjan, Leila M. Soravia

    Background: Classic psychedelics show potential for treating psychiatric disorders, yet the psychological framework of psychedelic-assisted therapy (PAT) remains underspecified. As regulatory approval approaches, defining the contribution of psychological interventions to clinical outcomes is critical for both mechanism inference and implementation. Objectives: To systematically review the structure, content, and duration of psychological interventions in contemporary clinical trials of serotonergic psychedelics for psychiatric symptoms, and to map the state of current approaches to inform future trial designs. Design: A systematic review following PRISMA guidelines. Data Sources and Methods: A systematic literature search was performed across PubMed, PsycINFO, and SCOPUS. Inclusion criteria targeted clinical trials administering serotonergic psychedelics (lysergic acid diethylamide (LSD), psilocybin, or dimethyltryptamine (DMT)) for psychiatric symptoms. Two reviewers independently screened studies and extracted data on dosing frameworks and psychological interventions. Results: We identified 44 trials (1,537 participants), covering depressive symptoms (n=20), substance use disorders (n=8), life-threatening illness-related distress (n=8), anxiety disorders (n=2), and other indications (n=6). Nearly all trials followed a three-phase preparation–dosing–integration structure, and dosing regimens showed increasing standardization. Psychological support, however, varied substantially: non-dosing sessions ranged from zero to 17, and frameworks spanned minimal/non-directive support to manualized established approaches (e.g., ACT, CBT). These interventions were frequently tailored by clinical indication, such as utilizing motivational enhancement for substance use disorders and addressing existential themes for life-threatening illnesses. Conclusion: Despite convergence on a shared procedural structure, PAT protocols remain highly heterogeneous in psychological embedding and orientation, reflecting tension between clinical depth and scalability. Because psychedelics are typically administered within a psychological context, this heterogeneity complicates efforts to isolate pharmacological from contextual effects, and existing evidence suggests the therapeutic context may itself moderate safety and efficacy. Advancing the field requires dismantling trials isolating psychological components and applying the same empirical rigor to psychotherapeutic as to pharmacological parameters.

  • Open Access

    From work-related trauma to suicidal ideation: a serial mediation model of posttraumatic stress and depression in rescue workers

    by Leila M. Soravia, Gianluca A. Florineth, Thomas Müller, Sebastian Walther, Mario Pfammatter, Niklaus Denier, Tobias Bracht, Kristina Adorjan

    Objectives: Rescue workers face frequent occupational trauma, increasing their risk for posttraumatic stress symptoms (PTSS), depression, and suicidal ideation. However, pathways linking trauma to suicidality remain poorly understood. This study investigated these mechanisms by testing a serial mediation model. Methods: From a larger survey of Swiss rescue workers, participants reporting suicidal ideation (n = 44) were matched by age, sex, and profession with a control group without suicidal ideation (n = 44). Symptomatology was assessed using validated questionnaires such as the Posttraumatic Stress Scale-10 (PTSS-10) for posttraumatic stress and the Brief Symptom Inventory (BSI) for depressive symptoms. Structural Equation Modeling (SEM) was employed to test a serial two-mediator model: Trauma Exposure - PTSS - Depressive Symptoms - Suicidal Ideation. Results: Participants with suicidal ideation had significantly higher levels of trauma, PTSS, and depressive symptoms. SEM confirmed an excellent model fit (χ² = 1.925, CFI = 1.000, RMSEA <.001) and a full mediation effect: trauma exposure was associated with PTSS, which in turn related to depressive symptoms, which were subsequently linked to suicidal ideation. The specific serial indirect pathway was significant (B = 0.143, p = .011), while the direct path from trauma to suicidal ideation was non-significant. The model explained 69.4% of the variance in suicidal ideation. Conclusion: The findings suggest a developmental pathway in which trauma exposure is associated with suicidal ideation through the sequential roles of PTSS and depressive symptoms. Consequently, suicide prevention for rescue workers should prioritize the management of post-traumatic and depressive symptoms to potentially disrupt this symptomatic progression.


  • Open Access

    Psilocybin-assistierte Gruppenpsychotherapie bei Abhängigkeitserkrankungen

    by Alexander Wopfner, Leila M. Soravia

    Zusammenfassung: Hintergrund: In der Schweiz kann Psilocybin im Rahmen von Ausnahmebewilligungen therapeutisch genutzt werden. Programm: Die Klinik Südhang entwickelte basierend auf Evidenz und Ethik ein standardisiertes Programm für Psilocybin-assistierte Gruppenpsychotherapie bei Abhängigkeitserkrankungen. Das quartalsweise durchgeführte Programm umfasst Diagnostik, mehrere Einzel- und Gruppensitzungen zur Vorbereitung, eine Psilocybin-Gruppensitzung sowie integrative Nachbesprechungen. Eine umfassende Qualitätssicherung, strenge Auswahlkriterien, spezifisch geschultes Personal und eine umfassende Vorbereitung erhöhen die Sicherheit. Das Gruppensetting fördert Ressourcen wie Zugehörigkeit, Akzeptanz und Mitgefühl und ermöglicht problemaktualisierende sowie klärende Erfahrungen. Erfahrungen: Bisher wurden in zwölf Zyklen 89 Behandlungen mit 36 Patient_innen ohne schwerwiegende Komplikationen durchgeführt. Schlussfolgerungen: Die Methode zeigt Potenzial für den Einsatz bei therapierefraktären Abhängigkeitserkrankungen, erfordert jedoch hohe therapeutische Kompetenz und institutionelle Ressourcen.


  • Open Access

    7 tesla multiscale entropy analysis reveals increased resting-state complexity in key regions for fear and anxiety in spider-fearful individuals

    by Matthias Grieder, Niklaus Denier, Kay Jann, Werner Strik, Leila M. Soravia, Kristina Adorjan, Marcel Meyer, Elisabeth Jehli


  • Altered Functional Coupling of the Bed Nucleus of the Stria Terminalis and Amygdala in Spider Phobic Fear

    by Elisabeth Jehli, Niklaus Denier, Andrea Federspiel, Thomas Dierks, Werner Strik, Leila M. Soravia, Matthias Grieder

    Background: Individuals with spider phobic (SP) fear show hypervigilance and amygdala hyperactivity toward fear-associated stimuli, which may promote the development of other anxiety disorders. The amygdala is a key region within the fear network, which is connected to the anxiety system, where the bed nucleus of the stria terminalis (BNST) plays a crucial role. However, the BNST’s involvement in phobic fear is unknown. Therefore, this study investigated the association of phobic fear and anxiety on these regions’ functional connectivity (FC) in SP compared to healthy controls (HC). Methods: 7T-functional MRI resting-state FC of 30 individuals with SP and 45 HC was assessed to detect network differences between these groups. The association of phobic fear severity, trait anxiety, and social anxiety on FC was explored using linear regressions combined with seed-to-voxel analyses with amygdala and BNST as primary seeds, corrected for age and sex. Results: In SP, phobic fear was associated with reduced FC between the left amygdala and the right supramarginal gyrus. In contrast, anxiety severity was related to increased FC between the right BNST and the left inferior frontal gyrus. Moreover, social anxiety was related to decreased FC between bilateral BNST and left precuneus. Conclusions: These findings show changes in FC in SP, connecting fear with altered activity in the BNST and amygdala. The results suggest that persistent anxiety in phobic fear is associated with abnormal brain function in these regions, potentially explaining susceptibility to anxiety disorders and processes involved in phobic fear, such as threat perception, avoidance, and salience.


  • Open Access

    Increased functional connectivity of amygdalar-frontal pathways in patients with alcohol use disorder and childhood trauma

    by Elisabeth Jehli, Fabienne Burri, Niklaus Denier, Franz Moggi, Andrea Federspiel, Roland Wiest, Maria Stein, Tobias Bracht, Matthias Grieder, Leila M. Soravia